Toffen Pharmaceuticals Private Limited - Due diligence report

A 360° intelligence report on Toffen Pharmaceuticals Private Limited: trust score, financial health, credit view, compliance, directors, gro…

2011-06-27 Navi Mumbai, Maharashtra Active Unlisted Active Non-Compliant
Share
Connect MCP
TP Toffen Pharmaceuticals Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Toffen Pharmaceuticals Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
68/100
Trust Score
Moderate

Toffen Pharmaceuticals Private Limited is assessed as Moderate with a Trust Score of 68/100. Toffen Pharmaceuticals Private Limited is an active private limited indian non-government company incorporated in 2011, operating in the Pharma sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.

Report generated on 26 Aug 2026 from the latest processed filings. Toffen Pharmaceuticals Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Good

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
68/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
55/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
80/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
55/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
60/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 4 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 55/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Moderate gearing (D/E 38%).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 2 open (10.88 cr) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Uco Bank2 48.0 cr
Compliance Score: 55/100 Moderate
  • Company status is Active as per MCA.
  • Marked ACTIVE non-compliant (INC-22A).
  • Last balance sheet is for Mar 2015 - filings overdue.
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
PULKIT MAHAJAN 01234567 Director 01/04/2018 6 yrs Approved
ANU PRADEEPKUMAR MAHAJAN 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • PULKIT MAHAJAN has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2015 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 60 · Distress 65
Growth signals & trust indicators
Profit expanded 1.42 year-on-year.
Operating for 15+ years.
Distress signals & risk flags
Revenue declined year-on-year.
Statutory filings appear overdue.
Compliance score is weak (55/100).
2 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence62/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment62/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 2 open charge(s) of 10.88 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view69/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 10 events
30 Sep 2015
Last AGM held
Annual general meeting
31 Mar 2015
Latest balance sheet
Filed with ROC
22 Feb 2014
Director ceased
ANIL KOHLI
01 Oct 2013
Director ceased
VIJAY KUMAR GUPTA
30 Mar 2012
Charge created
Uco Bank - 13.00 Lakh
07 Mar 2012
Charge created
Uco Bank - 10.75 cr
21 Feb 2012
Securities allotted
1562500.00 Equity Shares - 1.56 cr raised
27 Jun 2011
Incorporated
Registered with Roc Mumbai Ii
Director appointed
PULKIT MAHAJAN (Director)
Director appointed
ANU PRADEEPKUMAR MAHAJAN (Director)
10

Key Observations

Auto-generated from the data above
Debt-to-equity stands at 2.1x - manageable leverage.
Net worth is positive.
2 active director(s) / partner(s); review board churn before relying on management continuity.
Promoters hold a dominant controlling stake as per the FY 2015 annual return.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Pramanik Ayurveda Reinvented Private Limited U24233KL2013PTC033214 Kozhikode, Kerala, India
Bon Lon Petrochem Private Limited U11102DL1998PTC094300 Delhi, Delhi, India
Arvind Pharma Chem Private Limited U33111MH2012PTC232786 Mumbai, Maharashtra, India
Kavia Carbons Chennai Private Limited U23109TZ1996PTC008395 Dharapuram Tk Erode Dt, Tamil Nadu, India
Reshlon Cosmetics Private Limited U24246MH2005PTC154858 Thane West, Maharashtra, India
Option Petro Chem Private Limited U23200DL2012PTC237512 New Delhi, Delhi, India
Circular Plastics Private Limited U25111MH1985PTC038161 Mumbai, Maharashtra, India
Shri Durga Solvents Private Limited U24299KA2004PTC033341 Bangalore, Karnataka, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Toffen Pharmaceuticals Private Limited before audits and certifications: compliance score 55/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Toffen Pharmaceuticals Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 60/100, margin trends, ownership structure and peer set for Toffen Pharmaceuticals Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 68/100, distress signals and MSME payment-delay disclosures - know whether Toffen Pharmaceuticals Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Toffen Pharmaceuticals Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Toffen Pharmaceuticals Private Limited an active company?

Toffen Pharmaceuticals Private Limited has MCA status “Active” with a compliance score of 55/100 (Moderate).

Is Toffen Pharmaceuticals Private Limited financially healthy?

Toffen Pharmaceuticals Private Limited has a Financial Health Score of 80/100 (Low Risk) based on its filed financial statements.

Should I do business with Toffen Pharmaceuticals Private Limited?

Its overall Trust Score is 68/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Toffen Pharmaceuticals Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Toffen Pharmaceuticals Private Limited have loans or charges against its assets?

2 open charge(s) are registered against its assets.

Is Toffen Pharmaceuticals Private Limited up to date with its ROC filings?

Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 55/100 (Moderate).

Is it risky to lend to Toffen Pharmaceuticals Private Limited?

Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.